Evidence map›Paper›PMID 41282371›Full record

ArticleNature catalysis2025

De novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis.

Zhi Zou, Indrek Kalvet, Boris Lozhkin, Elinor Morris, Kailin Zhang, Dongping Chen, Marco L Ernst, Xiang Zhang, David Baker, Thomas R Ward

Abstract read
In one paragraph

Article in Nature catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Applications and limitations of AI tools in enzyme design.Protein science : a publication of the Protein Society · 2026
    Review
  4. Review
  5. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Review
  7. Tangled Tail of Mechanically Interlocked Peptides.Journal of the American Chemical Society · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  12. bioRxiv : the preprint server for biology · 2025
    Article
  13. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhi Zou *Department of Chemistry, University of Basel, Basel, Switzerland.ORCID 0000-0002-0815-8561
Indrek Kalvet *Department of Biochemistry, University of Washington, Seattle, WA USA.ORCID 0000-0002-6610-2857
Boris Lozhkin *Department of Chemistry, University of Basel, Basel, Switzerland.ORCID 0000-0001-5041-4015
Elinor MorrisDepartment of Chemistry, University of Basel, Basel, Switzerland.
Kailin ZhangDepartment of Chemistry, University of Basel, Basel, Switzerland.
Dongping ChenDepartment of Chemistry, University of Basel, Basel, Switzerland.ORCID 0000-0002-1537-1539
Marco L ErnstDepartment of Chemistry, University of Basel, Basel, Switzerland.ORCID 0009-0007-4110-5115
Xiang ZhangDepartment of Chemistry, University of Basel, Basel, Switzerland.ORCID 0009-0001-8977-6459
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA USA.ORCID 0000-0001-7896-6217
Thomas R WardDepartment of Chemistry, University of Basel, Basel, Switzerland.ORCID 0000-0001-8602-5468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase-an artificial metalloenzyme designed for ring-closing metathesis-for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity (

Indexed as

BiocatalysisMetalsOrganic chemistryProtein design

Identifiers

PMID41282371
PMCPMC12638248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.